J
Jasia Mahdi
H-index:9
Citation Count:1,313
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Harnessing the power of biomarkers for diffuse intrinsic pontine gliomas
利用生物标志物治疗弥漫性内生性脑桥胶质瘤
Nature Medicine
IF50
EVALUATION OF B7-H3 IMMUNOHISTOCHEMISTRY IN HIGH-GRADE GLIOMAS FOR CHIMERIC ANTIGEN RECEPTOR T-CELL PREDICTIVE TESTING
B7-H3免疫组织化学在高级别胶质瘤中用于嵌合抗原受体T细胞预测性检测的评价
NEURO-ONCOLOGY
IF13.4
HUMANIZED ANTI-CAR ANTIBODIES AFFECT DURABLE RESPONSE TO GD2-CAR T-CELLS IN DIFFUSE MIDLINE GLIOMA
人源化抗CAR抗体影响弥漫性中线胶质瘤中GD2-CAR T细胞的持久应答
NEURO-ONCOLOGY
IF13.4
Phase I study of intravenous and intracerebroventricular C7R-GD2.CAR T cell therapy for pediatric central nervous system (CNS) tumors
I期研究:静脉内和脑室内心肌内C7R-GD2.CAR T细胞疗法治疗儿童中枢神经系统(CNS)肿瘤
NEURO-ONCOLOGY
IF13.4
SINGLE-CELL LANDSCAPE OF B7H3-CAR T THERAPY IN GLIOMA: MECHANISMS OF RESISTANCE AND SIGNATURES OF LONG-TERM RESPONSE
单细胞景观揭示B7H3-CAR T疗法在胶质瘤中的抗药机制及长期应答特征
NEURO-ONCOLOGY
IF13.4
Clinical Impact of Intratumoral Cyst Decompression in Diffuse Intrinsic Pontine Glioma Patients: A Retrospective Analysis
弥漫性内生性脑桥胶质瘤患者中肿瘤内囊肿减压的临床影响:一项回顾性分析
NEURO-ONCOLOGY
IF13.4
Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review
中枢神经系统肿瘤经CAR T细胞疗法治疗后的神经毒性:一项综述
The promise of immunotherapy for central nervous system tumours
免疫疗法治疗中枢神经系统肿瘤的潜力
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas
正反观点:成人BRAF突变高级别胶质瘤的一线BRAF抑制治疗
NEURO-ONCOLOGY
IF13.4
TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
肿瘤炎症相关神经毒性 (TIAN): 中枢神经系统肿瘤免疫治疗患者的毒性综合征
NEURO-ONCOLOGY
IF13.4

